364. LATE-ONSET NEUTROPENIA IN PATIENTS UNDERGOING RITUXIMAB-INDUCED CONTINUOUS B CELL DEPLETION FOR AUTOIMMUNE DISEASE: DATA FROM A 738 PATIENT COHORT AND APPROACH TO MANAGEMENT
364. LATE-ONSET NEUTROPENIA IN PATIENTS UNDERGOING RITUXIMAB-INDUCED CONTINUOUS B CELL DEPLETION FOR AUTOIMMUNE DISEASE: DATA FROM A 738 PATIENT COHORT AND APPROACH TO MANAGEMENT is a paper indexed in PICO Portal from OpenAlex.
How many citations does 364. LATE-ONSET NEUTROPENIA IN PATIENTS UNDERGOING RITUXIMAB-INDUCED CONTINUOUS B CELL DEPLETION FOR AUTOIMMUNE DISEASE: DATA FROM A 738 PATIENT COHORT AND APPROACH TO MANAGEMENT have?
364. LATE-ONSET NEUTROPENIA IN PATIENTS UNDERGOING RITUXIMAB-INDUCED CONTINUOUS B CELL DEPLETION FOR AUTOIMMUNE DISEASE: DATA FROM A 738 PATIENT COHORT AND APPROACH TO MANAGEMENT has 1 citations in the OpenAlex counts PICO Portal stores.
When was 364. LATE-ONSET NEUTROPENIA IN PATIENTS UNDERGOING RITUXIMAB-INDUCED CONTINUOUS B CELL DEPLETION FOR AUTOIMMUNE DISEASE: DATA FROM A 738 PATIENT COHORT AND APPROACH TO MANAGEMENT published?
364. LATE-ONSET NEUTROPENIA IN PATIENTS UNDERGOING RITUXIMAB-INDUCED CONTINUOUS B CELL DEPLETION FOR AUTOIMMUNE DISEASE: DATA FROM A 738 PATIENT COHORT AND APPROACH TO MANAGEMENT has 2019 year in the PICO Portal index.
What is the open-access status of 364. LATE-ONSET NEUTROPENIA IN PATIENTS UNDERGOING RITUXIMAB-INDUCED CONTINUOUS B CELL DEPLETION FOR AUTOIMMUNE DISEASE: DATA FROM A 738 PATIENT COHORT AND APPROACH TO MANAGEMENT?
364. LATE-ONSET NEUTROPENIA IN PATIENTS UNDERGOING RITUXIMAB-INDUCED CONTINUOUS B CELL DEPLETION FOR AUTOIMMUNE DISEASE: DATA FROM A 738 PATIENT COHORT AND APPROACH TO MANAGEMENT has bronze oa status in the PICO Portal index.
What is the DOI of 364. LATE-ONSET NEUTROPENIA IN PATIENTS UNDERGOING RITUXIMAB-INDUCED CONTINUOUS B CELL DEPLETION FOR AUTOIMMUNE DISEASE: DATA FROM A 738 PATIENT COHORT AND APPROACH TO MANAGEMENT?
The DOI for 364. LATE-ONSET NEUTROPENIA IN PATIENTS UNDERGOING RITUXIMAB-INDUCED CONTINUOUS B CELL DEPLETION FOR AUTOIMMUNE DISEASE: DATA FROM A 738 PATIENT COHORT AND APPROACH TO MANAGEMENT is on the source record.
What is the OpenAlex record for 364. LATE-ONSET NEUTROPENIA IN PATIENTS UNDERGOING RITUXIMAB-INDUCED CONTINUOUS B CELL DEPLETION FOR AUTOIMMUNE DISEASE: DATA FROM A 738 PATIENT COHORT AND APPROACH TO MANAGEMENT?
The OpenAlex for 364. LATE-ONSET NEUTROPENIA IN PATIENTS UNDERGOING RITUXIMAB-INDUCED CONTINUOUS B CELL DEPLETION FOR AUTOIMMUNE DISEASE: DATA FROM A 738 PATIENT COHORT AND APPROACH TO MANAGEMENT is on the source record.